Join to View Full Profile
875 Blake Wilbur DrPalo Alto, CA 94305
Dr. Beygi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sara Beygi is a hematologist oncologist in Palo Alto, CA. She received her medical degree from Tehran University of Medical Sciences and has been in practice 11 years. She specializes in hematology and oncology and has expertise in lymphoid malignancies. She has numerous publications and citations.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2018 - 2021
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2015 - 2018
Tehran Univerisiry of Medical SciencesClass of 2013
Certifications & Licensure
CA State Medical License 2018 - 2025
PA State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Research Training Award for Fellows American Society of Hematology (ASH), 2021
- Summa cum laude Tehran University of Medical Sciences, 2013
Publications & Presentations
PubMed
- The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysis.Eve H Limbrick-Oldfield, Steve Kanters, Markqayne D Ray, Timothy Best, Madhu Palivela
Ejhaem. 2025-02-01 - 1 citationsMatching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma.Markqayne D Ray, Steve Kanters, Sara Beygi, Timothy Best, Jacob Wulff
Transplantation and Cellular Therapy. 2024-09-01 - A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma.Paola Ghione, M Lia Palomba, Markqayne D Ray, Eve H Limbrick-Oldfield, Jessica Owen
Clinical Lymphoma, Myeloma & Leukemia. 2024-05-01
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
